Search
Close this search box.

Blog

Media

Potentially promising Alzheimer’s drug going forward

A drug created by the company Biogen might be able to slow the progression of Alzheimer’s Disease.

The company initially discontinued work on aducanumab when it started with disappointing results. They now say that a further analysis of that same data has actually suggested it may decrease cognitive loss in its treatment of Alzheimer’s Disease.

Dr. Andrew Frank speaks with Rob Snow on 580 CFRA

Dr. Andrew Frank of Bruyère spoke about it yesterday on CFRA. Dr. Frank suggests further trials will be necessary, but that this remains a positive development in the world of dementia.

Related Posts

Media
En 2023, votre soutien a joué un rôle essentiel dans le maintien de la Société de la démence en tant que ressource communautaire accessible et[...]
Media
In 2023, your support played a critical role in maintaining The Dementia Society as an accessible, vital community resource. Thanks to your generosity, thousands of[...]
For Immediate Release Ottawa, ON – September 20, 2023 – The Dementia Society of Ottawa and Renfrew County will be hosting the BrainyActive Walk for[...]
Article
Real-life learning or clinical experience is difficult to get as we emerge from the  pandemic. Many healthcare environments are still operating at reduced levels or under restrictive[...]
Article
At The Dementia Society, we know that knowledge about brain health and dementia play a crucial role to reduce risks and prevent some forms of[...]
Article
Did you know that one in five Canadians experiences caregiving for someone living with dementia? Numbers also suggest that one in five of those caregivers[...]